blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3693392

EP3693392 - FULLY HUMAN ANTI-B CELL MATURATION ANTIGEN (BCMA) SINGLE CHAIN VARIABLE FRAGMENT, AND APPLICATION THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  10.07.2020
Database last updated on 05.07.2024
FormerThe international publication has been made
Status updated on  10.08.2019
Most recent event   Tooltip08.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Innovent Biologics (Suzhou) Co., Ltd.
168 Dongping Street
Suzhou Industrial Park
Suzhou, Jiangsu 215123 / CN
[2020/33]
Inventor(s)01 / LI, Zhiyuan
INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
168 Dongping Street
Suzhou Industrial Park Suzhou
Jiangsu 215123 / CN
02 / ZHAI, Tianhang
INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
168 Dongping Street
Suzhou Industrial Park Suzhou
Jiangsu 215123 / CN
03 / ZHOU, Shuaixiang
INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
168 Dongping Street
Suzhou Industrial Park Suzhou
Jiangsu 215123 / CN
04 / YU, Dechao
INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
168 Dongping Street
Suzhou Industrial Park Suzhou
Jiangsu 215123 / CN
 [2020/33]
Representative(s)Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2020/33]Teuten, Andrew John
Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
Application number, filing date19747676.501.02.2019
[2020/33]
WO2019CN74419
Priority number, dateCN20181010054901.02.2018         Original published format: CN201810100549
[2020/33]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019149269
Date:08.08.2019
Language:ZH
[2019/32]
Type: A1 Application with search report 
No.:EP3693392
Date:12.08.2020
Language:EN
[2020/33]
Search report(s)International search report - published on:CN08.08.2019
(Supplementary) European search report - dispatched on:EP03.12.2021
ClassificationIPC:C07K19/00, C07K16/28, C12N15/62, C12N15/63, C12N5/10, A61K38/17, A61P35/00
[2021/35]
CPC:
C07K16/2878 (EP,CN,US); A61P35/00 (EP,CN); A61P37/02 (EP);
G01N33/56972 (EP); G01N33/57426 (EP); G01N33/57484 (CN);
G01N33/57492 (US); A61K2039/505 (CN); C07K2317/21 (EP);
C07K2317/24 (US); C07K2317/41 (US); C07K2317/56 (CN);
C07K2317/565 (CN,US); C07K2317/622 (EP,CN,US); C07K2317/64 (EP);
C07K2317/92 (EP,CN,US); G01N2333/70578 (CN) (-)
Former IPC [2020/33]C07K16/28, C07K19/00, C07K14/725, C12N15/62, C12N15/13, C12N15/12, A61P35/00, A61P37/02, G01N33/68, G01N33/574
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/33]
TitleGerman:VOLLSTÄNDIG MENSCHLICHES EINZELKETTIGES VARIABLES FRAGMENT GEGEN B-ZELLREIFUNGSANTIGEN (BCMA) UND SEINE VERWENDUNG[2020/33]
English:FULLY HUMAN ANTI-B CELL MATURATION ANTIGEN (BCMA) SINGLE CHAIN VARIABLE FRAGMENT, AND APPLICATION THEREOF[2020/33]
French:FRAGMENT VARIABLE À CHAÎNE UNIQUE ANTI-ANTIGÈNE DE MATURATION DES LYMPHOCYTES B (BCMA) ENTIÈREMENT HUMAIN, ET APPLICATION ASSOCIÉE[2020/33]
Entry into regional phase29.04.2020Translation filed 
29.04.2020National basic fee paid 
29.04.2020Search fee paid 
29.04.2020Designation fee(s) paid 
29.04.2020Examination fee paid 
Examination procedure29.04.2020Examination requested  [2020/33]
28.06.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
15.01.2021Renewal fee patent year 03
07.01.2022Renewal fee patent year 04
20.12.2022Renewal fee patent year 05
08.01.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2014089335  (AMGEN INC [US]) [I] 1-18 * examples 5B-5C *;
 [I]WO2015166073  (MAX DELBRÜCK CT FÜR MOLEKULARE MEDIZIN [DE]) [I] 1-18 * page 43, line 15 - line 16 * * page 49, line 27 - line 30 * * page 5, line 1 - line 16 * * page 55, line 22 - line 24 *;
 [ID]WO2016014789  (BLUEBIRD BIO INC [US]) [ID] 1-18* examples 1,4 *;
 [I]WO2016090327  (SLOAN KETTERING INST CANCER [US], et al) [I] 1-18 * page 112; example 2 * * page 114, line 14 - line 16 * * page 115; table 20 *;
 [I]US2016297885  (KUO TRACY CHIA-CHIEN [US], et al) [I] 1-18 * example 1 * * page 82 - page 85; tables 6A-6C *;
 [I]WO2017021450  (ENGMAB AG [CH]) [I] 1-18 * page 72, line 1 - line 3 * * page 75; tables 2D, 2E * * page 78; table 4 *;
 [I]WO2017083511  (US HEALTH [US], et al) [I] 1-18 * example 3 * * page 35; table 1 *
International search[A]WO2010104949  (BIOGEN IDEC INC [US], et al) [A] 1-27 * entire document *;
 [A]EP3023437  (ENGMAB AG [CH]) [A] 1-27 * entire document *;
 [A]CN105837693  (LI SIWEN, et al) [A] 1-27 * entire document *;
 [A]CN106279418  (GLAXO GROUP LTD) [A] 1-27 * claims 1-30 *;
 [A]  - WUERTZER, C.A. et al., "anti-prion protein 6:4 single-chain variable fragment, partial [synthetic construct", PROTEIN, (20160726), Database accession no. ABX83198.1, URL: NCBI, XP055627849 [A] 1-27 * , entire document *
 [A]  - LEE, C.V. et al., "Synthetic Anti- BR 3 Antibodies that Mimic BAFF Binding and Target Both Human and Murine B Cells", Blood, (20060713), vol. 108, no. 9, pages 3103 - 3111, XP002509032 [A] 1-27

DOI:   http://dx.doi.org/10.1182/blod-2006-03-011031
by applicantUS4458066
 US4816567
 EP0367166
 US4956778
 EP0404097
 US5091513
 US5132405
 WO9301161
 US5208020
 US5336603
 US5500362
 US5622929
 US5648237
 WO9730087
 US5789199
 US5821337
 US5840523
 WO9858964
 WO9922764
 US5959177
 WO9951642
 US6040498
 WO0061739
 US6171586
 US6194551
 WO0129246
 US6267958
 EP1176195
 WO0231140
 US6417429
 US6420548
 US2002164328
 WO03011878
 US2003115614
 US6602684
 US2003157108
 WO03085119
 WO03084570
 WO03085107
 US2004093621
 US2004110704
 US2004110282
 US2004109865
 US2004132140
 WO2004056312
 WO2005035586
 WO2005035778
 US2005123546
 WO2005053742
 US2005196754
 WO2005100402
 WO2006029879
 WO2006044908
 US7125978
 US2007274985
 WO2008077546
 WO2009036379
 WO2010105256
 US2011076752
 WO2012009568
 WO2012138475
 WO2014087010
 US2017226216
 US9845464
    - RICKERT et al., Immunological Reviews, (20110000), vol. 244, pages 115 - 133
    - HAHNE et al., T.Exp. Med., (19980000), vol. 188, pages 1185 - 90
    - BLOOD, (20140500), vol. 123, no. 20, pages 3128 - 3138
    - VINCENT, Nature Reviews Rheumatology, (20140000), vol. 10, pages 365 - 373
    - MATHER, J. P. et al., Annals N.Y. Acad. Sci., (19820000), vol. 383, pages 44 - 68
    - HELLSTROM, I. et al., Proc. Nat'l Acad. Sci. USA, (19850000), vol. I&II, pages 1499 - 1502
    - ROSENFELD et al., Cell, (19920000), vol. 68, page 143
    - CLACKSON, T. et al., Nature, (19910000), vol. 352, pages 624 - 628
    - PORTOLANO, S. et al., J. Immunol., (19930000), vol. 150, pages 880 - 887
    - HUDSON, Mat. Med., (20030000), vol. 9, pages 129 - 134
    - HOLLINGER, PNAS USA, (19930000), vol. 90, pages 6444 - 6448
    - HUDSON, Nat. Med., (20030000), vol. 9, pages 129 - 134
    - XU et al., Protein Engineering, Design & Selection, (20130000), vol. 26, no. 10, pages 663 - 670
    - FLATMAN, S. et al., J.Chrom.B, (20070000), vol. 848, pages 79 - 87
    - MATTILA et al., Nucleic Acids Res., (19910000), vol. 19, page 967
    - CHOTHIALESK, J. mol. biol., (19870000), vol. 196, pages 901 - 917
    - SHEN et al., Anal. Chem., (20080000), vol. 80, no. 6, pages 1910 - 1917
    - LIU, PNAS, (19970000), pages 5525 - 5530
    - KIM, PNAS, (19960000), vol. 93, pages 1156 - 1160
    - CHAUDHARY, Proc.Natl.Acad.Sci. U.S.A., (19900000), vol. 87, pages 1066 - 1070
    - BIRD, Science, (19880000), vol. 242, pages 423 - 426
    - DESJAAISBERG, PNAS, (19930000), vol. 90, pages 2256 - 2260
    - PNAS, (19940000), vol. 91, pages 11099 - 11103
    - HUSTON, Proc. Nat. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883
    - IDUSOGIE, E. E. et al., J. Immunol., (20000000), vol. 164, pages 4178 - 4184
    - OKAZAKI, A. et al., J. mol. biol., (20040000), vol. 336, pages 1239 - 1249
    - YAMANE-OHNUKI, N. et al., Biotech. Bioeng., (20040000), vol. 87, no. 614, pages 614 - 622
    - RIPKA, J. et al., Arch. Biochem. Biophys., (19860000), vol. 249, pages 533 - 545
    - KANDA, Y. et al., Biotechnol. Bioeng., (20060000), vol. 94, pages 680 - 688
    - TARENTINO et al., Biochem., (19750000), vol. 14, pages 5516 - 23
    - HELLSTROM, I. et al., Proc. Nat'l Acad. Sci. USA, (19860000), vol. 83, pages 7059 - 7063
    - BRUGGEMANN, M. et al., J. Exp. Med., (19870000), vol. 166, pages 1351 - 1361
    - CLYNES, R. et al., Proc. Nat'l Acad. Sci. USA, (19980000), vol. 95, pages 652 - 656
    - GAZZANO-SANTORO, H. et al., J. Immunol. Methods, (19960000), vol. 202, pages 163 - 171
    - CRAGG, M.S. et al., Blood, (20030000), vol. 101, pages 1045 - 1052
    - CRAGG, M.S.M.J. GLENNIE, Blood, (20040000), vol. 103, pages 2738 - 2743
    - NARANG et al., Meth. Enzymol., (19790000), vol. 68, page 109
    - BEAUCAGE et al., Tetra. Lett., (19810000), vol. 22, page 1859
    - ECKERT et al., PCR Methods and Applications, (19910000), vol. 1, page 17
    - HARRINGTON et al., Nat Genet, (19970000), vol. 15, page 345
    - SMITH, Annu. Rev. Microbiol., (19950000), vol. 49, page 807
    - SCHARF et al., Results Probl. Cell Differ., (19940000), vol. 20, page 125
    - BITTNER et al., Meth. Enzymol., (19870000), vol. 153, page 516
    - BLASIE et al., Gene, (20040000), vol. 342, pages 211 - 218
    - GERNGROSS, Nat. Biotech., (20040000), vol. 22, pages 1409 - 1414
    - LI, H. et al., Nat. Biotech, (20060000), vol. 24, pages 210 - 215
    - GRAHAM, F. L. et al., J. Gen Virol., (19970000), vol. 36, page 59
    - MATHER, J. P., Biol. Reprod., (19800000), vol. 23, pages 243 - 251
    - URLAUB, G. et al., Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, pages 4216 - 4220
    - BODERWITTRUP, Nat. Biotechnol., (19970000), vol. 15, pages 553 - 557
    - SAZINSKY et al., Proc. Natl. Acad. Sci. USA, (20080000), vol. 105, pages 20167 - 20172
    - TASUMI et al., Proc. Natl. Acad. Sci. USA, (20090000), vol. 106, pages 12891 - 12896
    - KURODAUEDA, Biotechnol. Lett., (20110000), vol. 33, pages 1 - 9
    - RAKESTRAW et al., PEDS, (20110000), vol. 24, pages 525 - 530
    - DERNICK, G. et al., J. Lipid Res., (20110000), vol. 52, pages 2323 - 2331
    - ESTEP, P et al., "High throughput solution Based measurement of antibody-antigen affinity and epitope binding", MAbs, (20130000), vol. 5, no. 2, doi:10.4161/mabs.23049, pages 270 - 8, XP055105281

DOI:   http://dx.doi.org/10.4161/mabs.23049
    - CHARI et al., Cancer Research, (19920000), vol. 52, pages 127 - 131
    - ESTEP, P et al., "High throughput solution Based measurement of antibody-antigen affinity and epitope binning", MAbs, (20130000), vol. 5, no. 2, doi:10.4161/mabs.23049, pages 270 - 8, XP055105281

DOI:   http://dx.doi.org/10.4161/mabs.23049
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.